WithdrawnNot Applicable

Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage

Stopped: unsuccessful recruitment

Canada0Started 2012-05-24

Plain-language summary

This study aims to look at the necessity for prescribing antibiotics post-drainage of peritonsillar abscesses (PTA). This will be a single-blinded randomized-control trial with two arms - patients receiving placebo versus those receiving a seven day course of oral Amoxicillin-Clavulanic acid. The main objective measure will be to assess if there is resolution of the peri-tonsillar abscess and there has been no reaccumulation. Patients will be blinded to whether they receive placebo or amoxicillin-clavulanic acid. Patients will be phoned after 7 days to assess if their symptoms have resolved via an over the phone questionnaire. Anaerobic and aerobic cultures will be obtained.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Older than 18 years of age * Diagnosed with a peritonsillar abscess that has been drained and purulence has been obtained Exclusion Criteria: * Pregnant * Under the age of 18 * Bilateral peritonsillar abscesses * Recently drained peritonsillar abscess * Immunocomprimised

What they're measuring

Re-accumulation of the patient's peri-tonsillar abscess

Timeframe: 30 days

Trial details

NCT IDNCT01715610

SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-11-30

View on ClinicalTrials.gov More Peritonsillar Abscess trials